Switch to: References

Add citations

You must login to add citations.
  1. Who are the guardians guarding?Howard Trachtman - 2002 - American Journal of Bioethics 2 (3):46 – 48.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  • Life, death, and monopoly rights in a democratic society.Simon J. Smith - 2002 - American Journal of Bioethics 2 (3):43 – 44.
  • Patents: The public interest versus the private privilege.Kayhan P. Parsi & Erin A. Egan - 2002 - American Journal of Bioethics 2 (3):45 – 46.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  • Not Taking, Just Borrowing: Government Use of Patented Drugs.Pilar N. Ossorio - 2002 - American Journal of Bioethics 2 (3):51-52.
  • It Is Not Unethical, Though It Is Often Unwise, to Override Patents.Herb Leventer - 2002 - American Journal of Bioethics 2 (3):50-51.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  • The cipro patent and bioterrorism.Keith S. Kaye & Donald Kaye - 2002 - American Journal of Bioethics 2 (3):41 – 42.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  • Access to Essential Medicines: A Hobbesian Social Contract Approach.Richard E. Ashcroft - 2005 - Developing World Bioethics 5 (2):121-141.
    ABSTRACT Medicines that are vital for the saving and preserving of life in conditions of public health emergency or endemic serious disease are known as essential medicines. In many developing world settings such medicines may be unavailable, or unaffordably expensive for the majority of those in need of them. Furthermore, for many serious diseases (such as HIV/aids and tuberculosis) these essential medicines are protected by patents that permit the patent‐holder to operate a monopoly on their manufacture and supply, and to (...)
    Direct download  
     
    Export citation  
     
    Bookmark   1 citation  
  • Beyond government intervention: Drug companies and bioethics.Rebecca Dresser - 2002 - American Journal of Bioethics 2 (3):42 – 43.
  • Fair Drug Prices and the Patent System.David B. Resnik - 2004 - Health Care Analysis 12 (2):91-115.
    This paper uses John Rawls' theory of justice to defend the patent system against charges that it has an unfair effect on access to medications, from the perspective of national and international justice. The paper argues that the patent system is fair in a national context because it respects intellectual property rights and it benefits the least advantaged members of society by providing incentives for inventors, investors, and entrepreneurs. The paper also argues that the patent system is fair in an (...)
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  • Patent immorality?M. Gregg Bloche & Elizabeth R. Jungman - 2002 - American Journal of Bioethics 2 (3):48 – 49.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  • Access to essential medicines: A Hobbesian social contract approach.Richard E. Ashcroft - 2005 - Developing World Bioethics 5 (2):121–141.
    ABSTRACTMedicines that are vital for the saving and preserving of life in conditions of public health emergency or endemic serious disease are known as essential medicines. In many developing world settings such medicines may be unavailable, or unaffordably expensive for the majority of those in need of them. Furthermore, for many serious diseases these essential medicines are protected by patents that permit the patent‐holder to operate a monopoly on their manufacture and supply, and to price these medicines well above marginal (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   2 citations